Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-04-01 17:45 |
Valneva : le vaccin contre le chikungunya, IXCHIQ®, désormais autorisé chez les…
|
French | 231.2 KB | ||
| 2025-03-31 07:00 |
Valneva soumet à la MHRA une demande d’élargissement de l’indication aux adoles…
|
French | 227.9 KB | ||
| 2025-03-31 07:00 |
Valneva Submits Adolescent Label Extension Application for its Chikungunya Vacc…
|
English | 204.2 KB | ||
| 2025-03-26 18:00 |
Valneva renouvelle son contrat de placement (Sales Agreement) dans le cadre de …
|
French | 141.2 KB | ||
| 2025-03-26 18:00 |
Valneva Renews its Sales Agreement in connection with its Existing At-the-Marke…
|
English | 187.0 KB | ||
| 2025-03-25 07:00 |
Valneva Announces Filing of 2024 Universal Registration Document and US Form 20…
|
English | 110.8 KB | ||
| 2025-03-25 07:00 |
Valneva annonce le dépôt de son Document d’Enregistrement Universel 2024 et de …
|
French | 120.6 KB | ||
| 2025-03-24 17:14 |
Document d'enregistrement universel 2024
|
French | 60.3 MB | ||
| 2025-03-24 07:00 |
Valneva répond à l'appel du gouvernement français pour la fourniture du vaccin …
|
French | 251.8 KB | ||
| 2025-03-24 07:00 |
Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® agai…
|
English | 269.1 KB | ||
| 2025-03-20 07:00 |
Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook
|
English | 360.7 KB | ||
| 2025-03-20 07:00 |
Valneva publie ses résultats financiers 2024 et fait un point sur son activité …
|
French | 339.0 KB | ||
| 2025-03-05 18:00 |
VALNEVA Déclaration d’actions et de droits de vote : 28 février 2025
|
French | 14.1 KB | ||
| 2025-03-05 18:00 |
VALNEVA Declaration of shares and voting rights: February 28, 2025
|
English | 14.3 KB | ||
| 2025-03-03 07:00 |
Valneva fera une présentation lors des conférences investisseurs TD Cowen et Va…
|
French | 100.5 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
